Together, these findings suggest that Nrp2 and Ncam1 double-expressing cells represent rare MSC able to differentiate toward the fibrotic and the osteogenic trajectory driving myelofibrosis and osteosclerosis. The gene discussed is NRP2; the disease is osteosclerosis.